Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$45.2K Sell
29,516
-200
-0.7% -$304 ﹤0.01% 3421
2026
Q1
$53.8K Buy
29,716
+7,442
+33% +$12.9K ﹤0.01% 3415
2025
Q4
$30.1K Sell
22,274
-38
-0.2% -$54 ﹤0.01% 3459
2025
Q3
$36.4K Buy
22,312
+46
+0.2% +$51 ﹤0.01% 3474
2025
Q2
$21.6K Buy
22,266
+3,223
+17% +$2.67K ﹤0.01% 3416
2025
Q1
$13.4K Buy
+19,043
New +$13.2K ﹤0.01% 3402
2023
Q4
Sell
-29,605
Closed -$11.8K 3144
2023
Q3
$11.8K Buy
+29,605
New +$14.6K ﹤0.01% 2867
2022
Q4
Sell
-10,175
Closed -$18K 2807
2022
Q3
$18K Buy
+10,175
New +$25.3K ﹤0.01% 2387

Other funds holding OCGN

Mariner's OCGN Position: Q2 2026 in Review

Mariner reduced its Ocugen (OCGN) stake by 0.67% in Q2 2026, selling an estimated $304 and leaving 29,516 shares worth $45.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3421.

Mariner first reported a position in OCGN in Q3 2022 and has held it in 8 quarters since. The position peaked at $53.8K in Q1 2026. 148 funds tracked by Wall St. Rank hold OCGN as of Q2 2026.

  • Mariner held 29,516 shares of Ocugen worth $45.2K as of Q2 2026.
  • Mariner sold 200 Ocugen shares in Q2 2026, an estimated $304.
  • Ocugen made up ﹤0.01% of Mariner's portfolio in Q2 2026, its #3421 holding.
  • Mariner first reported a position in Ocugen in Q3 2022 and has held it in 8 quarters since.
  • Mariner's Ocugen position peaked at $53.8K in Q1 2026.
  • 148 funds tracked by Wall St. Rank held Ocugen as of Q2 2026.

Based on Mariner's 13F filing for Q2 2026, filed 13 Aug 2026.